CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

free stock cash Tips

Wednesday, February 26, 2014


·         Tata Power extends Tuesday's slide
Tata Power Company lost 1.48% with the stock extending recent fall triggered by equity dilution worries after the firm said its board of directors will meet on 27 February 2014 to consider various fund raising options.

·         Lupin receives FDA approval for generic Mycobutin capsules

Lupin Ltd announced that it has received final approval for its Rifabutin Capsules USP, 150 mg from the United States Food and Drugs Administration to market a generic version of Pharmacia and Upjohn Company’s Mycobutin Capsules 150 mg.

·         Arvind Remedies inches up after commencement of commercial operations at a unit

Arvind Remedies rose 0.82% after the company said that on 20 February 2014 the commercial operation of the new unit of the company at Kakkalur, Tiruvellore, Tamil Nadu for few products has been started.

·        Dr Reddy's at new high, launches headache drug Sumatriptan              

Dr Reddy’s Laboratories gained nearly 2% at Rs 2,823, after touching a record high of 2,845 earlier in the day, after the company said it has launched Sumatriptan Injection USP in the US.


Post a Comment